Precision in Quantitative Imaging: Trial Development and Quality Assurance

Similar documents
AAPM Scientific Meeting Imaging Symposium. State of the Art in Quantitative Imaging CT, PET and MRI. Which Imaging Modality is the Most Quantitative

CQIE MRI PROCEDURES. American College of Radiology Clinical Research Center. Centers for Quantitative Imaging Excellence LEARNING MODULE

Introduction to Quantitative Imaging as a Biomarker in Clinical Trials

CQIE PET PROCEDURES. American College of Radiology Clinical Research Center. Centers for Quantitative Imaging Excellence LEARNING MODULE

From Analysis Method to Quantitative Imaging Biomarker

NIST Medical Imaging Informatics Activities. Medical Imaging

Images as Biomarkers potential future advances in the field as viewed by ISPY-2. Nola Hylton, PhD University of California, San Francisco

DCE MRI Team Activity. Gudrun Zahlmann, Edward Jackson, Sandeep Gupta

Quantitative Imaging Biomarker DCE - MRI

Progress Towards an International Image Quality Monitoring Framework for Quantitative Imaging

Facilitating the Use of Imaging Biomarkers in Therapeutic Clinical Trials. Michael Graham, PhD, MD President, SNM Co-chair, Clinical Trials Network

Jeffrey T. Yap, Ph.D. Dana-Farber Cancer Institute Brigham & Women s Hospital Harvard Medical School

UPICT template structure as modified by QIBA VolCT Technical Committee June 25, 2009

Accuracy, Precision and Measurement Validation

Evaluation of 1D, 2D and 3D nodule size estimation by radiologists for spherical and non-spherical nodules through CT thoracic phantom imaging

QIBA Working Session

2017 ACR Computed Tomography Quality Control Manual FAQS

REPEATABILITY, REPRODUCIBILITY AND ANALYTIC STANDARDS FOR BIOMARKER DEVELOPMENT

PET in clinical trials

Clarity CT Technology

RADIATION ONCOLOGY RESIDENCY PROGRAM Competency Evaluation of Resident

BIOMARKER DISCOVERY IN LOCALLY ADVANCED CERVICAL CANCER: IQ-EMBRACE PETRA VAN HOUDT, JESPER KALLEHAUGE, UULKE VAN DER HEIDE, KARI TANDERUP MARCH 23,

Informatics Tools for Optimized Imaging Biomarkers for Cancer Research & Discovery

Quantitative biomarker for clinical decision making

Connect and Deliver Optima CT580 RT

Infrastructure to Integrate Imaging in Clinical Trials

Part 3 Oral Exam Content Guide

Methods in Clinical Cancer Research Workshop Format for Protocol Concept Synopsis Sheet (blank) SYNOPSIS

QIBA Profile: Small Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening

Quality Control Concerns for New Generations of CT, MRI, & PET

GENESIS Edition. Transforming CT

8/2/2017. Key attributes of scientific excellence: rigor, innovation, and relevance. Medical Physics 3.0. Key Attributes of Scientific Excellence

CT post processing and low dose scanning

QIBA Profile: Small Lung Nodule Volume Assessment and Monitoring in Low Dose CT Screening

Advancing utility and adoption of clinical genomic diagnostics

USE OF PHANTOMS AND IMAGE DATASETS FOR

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

RSNA/SNM/FDA. Management of Image Data Workflow. Two Topic Imaging Workshop: Standards for Imaging Endpoints in Clinical Trials

Fast enough to stop the Capable of delineating Unprecedented imaging power for the. Virtual endoscopy. The gatewa

Profile: DCE MRI Quantification

Imaging/Imagine Needs for Proton Therapy: Treatment Planning. Lei Dong, Ph.D. Scripps Proton Therapy Center San Diego, CA

Trusted Performance. Smart Investment. 80 detector row Ultra Helical CT

Technical Guidance on Development of In Vitro Companion Diagnostics and Corresponding Therapeutic Products

QIN: Overview of Scientific Challenges

Profile: DCE MRI Quantification

Clinical Trial Design, Approval Process and Trial Conduct

WHY QIBA: MR SPECIFICS

Mirada Case Study. VentureFest, July

Not for publication in the USA Erlangen, November 26, 2017

An Automated Pipeline for NGS Testing and Reporting in a Commercial Molecular Pathology Lab: The Genoptix Case

Optimisation of Clinical Protocols

GENESIS Edition Transforming CT

T.W.I.S.T. IDEAL Radiological Imaging Services Presented by Adrienne Coya & Sandra Marcelin

Buy One, Get Two for Free: Simultaneous Knee T2 Mapping and Morphological Analysis On Synthetic Images Using GRAPPATINI

Technical Assessment (TA) Summary Form (M00116)

HHSN C Quantitative Imaging Biomarkers Alliance (QIBA)

Laboratory Accreditation Test Validation: A Brave New World for Anatomic Pathology

Introduction. FDA Approval. Breast Tomosynthesis From the Ground Up

PET/CT imaging for response monitoring in multicenter studies: An update and future challenges

Molecular Diagnosis Challenges & Solutions. Using Molecular Kits or Laboratory Developed Tests (Home Brew), Emphasis on Validation

Integrating Biospecimen Collection into Clinical Research

FFGWAS. Fast Functional Genome Wide Association AnalysiS of Surface-based Imaging Genetic Data

PRINCIPLES OF CT AND MR IMAGING Marc-André d Anjou, DMV, DACVR Faculty of Veterinary Medicine, University of Montreal Saint-Hyacinthe, Quebec, Canada

Role of PET/CT Imaging

FDA Regulation of Companion Diagnostics

Publication for the Philips MRI Community Issue 40 May 2010

Reporting Checklist for Nature Neuroscience

Ingenia MR-RT. MR Systems. The comprehensive MR-sim solution to fit your planning

Evidentiary Considerations for Integration of Biomarkers in Drug Development : Statistical Considerations

Lead the way. Molecular Imaging. GE Healthcare. imagination at work

Pushing the Leading Edge in Protein Quantitation: Integrated, Precise, and Reproducible Protein Quantitation Workflow Solutions

WHY QIBA: CT SPECIFICS

Creating a More Efficient Workflow for Reading High-Volume CT and MR Studies

Imaging Systems. Steve Rusckowski CEO Imaging Systems

Quantification in emission tomography: challenges, solutions, performance and impact

NCI Research Networks Model for Collaboration with Bioelectronics Round Table

Justification, Instrument Selection, and Due Diligence for Successful Implementation of MS. Objectives. Clinical Justification

SUMMARY OF CHANGES Amendment #2, Version Date: April 25, 2006

Making the difference with Live Image Guidance

CT QA SOLUTIONS. Ensure Accurate Screening, Diagnosis and Monitoring ACCREDITATION CT IMAGE QUALITY QA CTDI CT CHARACTERIZATION CT PERFUSION QA

Interventional Tumor Therapy Minimally Invasive, Maximally Effective

Trans NCI Initiatives Role of imaging as an enabling technology

What Can We Learn From Each Other?

Histology Pattern Recognition Software in Investigative Pathology

Computed Tomography: Optimization of acquisition protocols & Justification of clinical referrals. Koos Geleijns, medical physicist

QIBA RIC Collaboration

Guidance for Industry

N.MAFFEI, G.GUIDI, C.VECCHI, G.BALDAZZI Physics Department, University of Bologna, via Irnerio Bologna, Italy

An Automated Pipeline for NGS Testing and Reporting in a Commercial Molecular Pathology Lab: The Genoptix Case

03/08/2017. Advances and Challenges in Contour QA for Adaptive RT. Objective. Disclosures

Press Presse Press Presse

GE Healthcare. Introducing Discovery MI DISCOVERY MI

Guidance for the Physics Aspects of Clinical Trials

Statistical models for supporting medical diagnosis, therapy and training

Common Issues in Qualification and Validation of Analytical Procedures

New PET/CT from Siemens helps more patients benefit from premium technologies

GE Healthcare. PET/CT + MR Trimodality Imaging

IMAGE GUIDANCE DOSES IN RADIOTHERAPY. Scott Crowe

PATHOLOGICAL ASPECTS OF CLINICAL TRIALS. Prof. Dr. med. Christoph Röcken Dept. of Pathology Christian-Albrechts-University Kiel, Germany

Transcription:

Precision in Quantitative Imaging: Trial Development and Quality Assurance Susanna I Lee MD, PhD Thanks to: Mitchell Schnall, Mark Rosen. Dan Sullivan, Patrick Bossuyt

Imaging Chain: Patient Data Raw data Image reconstruction 123 2346.. 65789 6578.. Image analysis Image processing Data analysis Data output

Clinical Trials: Imaging is an Assay Disease Detection Screening Characterize Disease Diagnosis, eligibility or prognosis Anatomic distribution (e.g. tumor staging) Higher level features (e.g. heterogeneity, vascularity, etc.) Monitor Therapeutic Response Change in features with therapy Anatomic (e.g. RECIST) or functional (e.g. SUV)

Schema Diagnostic accuracy REFERENCE STANDARD OF DISEASE STATE PATHOLOGY CONFIRMATORY TEST FOLLOWUP ENROLLED PARTICIPANT INDEX TEST IMAGING EXAM IMAGE-GUIDED PROCEDURE MANAGEMENT STANDARD OF CARE STUDY DEFINED Biomarker REFERENCE STANDARD OF PATIENT OUTCOME OVERALL SURVIVAL (OS) PROGRESSION FREE SURVIVAL (PFS) OR DISEASE FREE SURVIVAL (DFS) TREATMENT RESPONSE

Cancer Biomarkers Imaging Tissue (e.g. hormone receptors, cytokeratins) PATIENT OUTCOME 1. Overall survival (OS) 2. Progression free survival (PFS) 3. Clinical response Serum (CA125, PSA, AFP, CA19-9) Genetic Genome Expression (e.g. RNA or protein)

What is a good biomarker? Stable technology Available widely Standardized image acquisition Reproducible Range of normal defined Balance state of the art with generalizability Sargent DJ, Rubinstein L, Schwartz L et al. Eur J Cancer 2009; 45: 290.

Variability: Test Retest Same patient, day, scanning protocol but separate imaging sessions Pre-treatment Post-treatment Range of test-retest Conclusion Index test variability precludes detecting pre- vs. post-treatment change. Lankester KJ, Taylor NJ, Stirling JJ et al. Br J Cancer. 2005.93:979.

Signal Requires Data Quality

Precision vs. Bias precise accurate not precise not accurate precise not accurate

Multiple Sclerosis MRI Image acquisition T1 T2 Post-gadolinium T1 Image analysis Number of new or enlarging lesions Number of enhancing lesions

MRI endpoint in MS treatment studies 157 publications from 1995 to 2006

Imaging Chain: Patient Data Raw data Image reconstruction 123 2346.. 65789 6578.. Image analysis Image processing Data analysis Data output

Imaging Manual Hardware and software Scanner calibration Patient preparation Scanning protocol Post-processing Image acquisition manual with a step by step description is part of any prospective study design.

What determines resolution? Physics of acquisition (i.e. modality) Sampling (e.g. matrix, detector size) Filtering and other contributions inherent in the reconstruction

Point Spread Function Patient Image

Image edges approximate anatomy Structure Real Edge Image Edge

Resolution and Sampling 160 x 160 matrix 320 x 224 matrix

Filtering 1 1 1 1 1 1 2 2 2 1 1 2 4 2 1 1 2 2 2 1 1 1 1 1 1

Filtering: MRI Vendor 1 Vendor 2

Filtering: X-ray Vendor 1 Vendor 2

Partial Volume Effects Completely in scan plane Partially in scan plane

Partial Volume Effects: CT Completely in scan plane Partially in scan plane HU = 0 HU = 30-60

Partial Volume Effects: PET lesion lesion Blurred margins Lower intensity

Quantitative Imaging Biomarkers Alliance (QIBA) Started by RSNA 2007 Mission: Improve the value and practicality of quantitative imaging biomarkers by reducing variability across devices, patients and time Build imaging devices that are also measuring devices Industrialize imaging biomarkers https://www.rsna.org/qiba/

QIBA Approach 1. Identify the sources of error and variability 2. Specify potential solutions in the form of profiles 3. Test these solutions 4. Promulgate profiles to vendors and users Purpose of profiles: Advise vendors what must be implemented in their product Communicate the necessary procedures to users

QIBA Profile Activity Diagram Equipment Assessment Subject Preparation Image Acquisition Image Reconstruction Image Analysis Interpretation Manufacturer specification (pre-delivery) Installation specification Maintenance Quality Assurance

ACR Core Lab QA Site qualification Instrument performance Training Monitoring of image acquisition Scan header for protocol compliance On-line technologist qualitative review Periodic radiologist review Centralized image analysis Post-processing Reader study

Require Site Protocol Compliance Type Orientation Pulse Sequence T1 weighted GRE Sagittal Dynamic 3D Field Of View (FOV) 16-18 cm Slice Thickness 64 slices of thickness 2.5 mm Skip Correct Matrix min. 256 x 192 Frequency A/P NEX 2 Phase Wrap NO Fat-Saturation YES Submitted TR Effective TE Scan Duration Flip angle 20 ms 4.5 ms Between 4.5 and 5 minutes <= 45 degrees ACRIN 6657 (I-SPY 1 trial), Nola Hylton, PI

Imaging Chain: Patient Data Raw data Image reconstruction 123 2346.. 65789 6578.. Image analysis Image processing Data analysis Data output

Image analysis: Turning image into data User extracted features Semi automated Automated Feature 1 Feature 2 Feature 3...

Radiomics: Deep Learning Untrained neural network

Radiomics: Deep Learning Trained neural network

Radiomics: Automated Image Analysis Improve diagnostic accuracy

Radiomics: Automated Image Analysis Triage clinical workflow

Semi-automated: Manual Segmentation Large image datasets segmented for tumor Quantitative feature extraction Model predictive indices Integrate with genomic & clinical data for machine learning Aerts HJ et al. Nat Commun. 2014 ;5:4006.

Reader Extracted Features Density Fluid, soft tissue, calcified Shape Round, oval, irregular Size Linear, volume Margin Sharp, blurred, spiculated Intensity high/medium/low/minimal Summary assement BIRADS level

ROC operating points of 108 radiologists reading same mammograms 1.0 0.8 Skill TP 0.6 0.4 0.2 Value judgments 0.0 0.0 0.2 0.4 0.6 0.8 1.0 FP Beam, Layde, Sullivan Arch Intern Med 1996; 156:209-213

Reader Variability: Size progression Increases and decreases of <10% can be a result of inherent variability. Oxnard GR et al. J Clin Oncol. 2011;29:3114-9.

Variability Introduced by ROI Selection Slice 483 Slice 479 Slice 479 SUV=4.0 SUV=5.6 SUV=6.6

Variability Introduced by ROI Selection All ROI protocols show excellent inter-observer agreement (ICC 0.94) Different ROI protocols yield different ADC values Priola AM et al. Eur Radiol. 2016 Aug 11.

Effect of Windowing Soft tissue window Liver window

Effect of Windowing Lung window Mediastinal window Significant measurement differences between window settings (p<0.001). No significant differences in measurement variability between the lung and mediastinal window settings (p>0.05). Kim H et al. PLoS One. 2016;11:e0148853.

Reader Study Reader blinded to reference standard Multiple readers Independent rather than consensus reads Rules for image interpretation Clinical information available to reader Image selection, windowing, order, etc. Choosing index lesions Selecting region of interest (ROI) Definition of positive vs. negative test Washout period between read sessions of paired imaging exams Digital data forms and screen to document reader study A manual defining reader rules and training cases are part of any prospective study design.

Overall trial framework Hypothesis and specific aims Participants Index test Reference standard Data analysis plan (statistics) Conclusions and implications Funding and compliance http://www.equator-network.org/reporting-guidelines/stard/

Index Test (Imaging Exam) STARD 10 - Index test, in sufficient detail to allow replication STARD 12 - Definition of and rationale for test positivity cut-offs or result categories of the index test, distinguishing pre-specified from exploratory STARD 13 - Whether clinical information and reference standard results were available to the performers/readers of the index test STARD 25 - Any adverse events from performing the index test

Steps toward precision: Define image acquisition Equipment, patient preparation, protocol Balance state of the art with generalizability Define image analysis Read rules, training and testing Validate the system Test-retest, reader agreement measurements Build in procedures for ongoing QA